SLNO — Soleno Therapeutics Share News
0.000.00%
- $2.76bn
- $2.56bn
- $190.41m
Brief: Soleno Therapeutics Announces Entry Into $100 Million Accelerated Share Repurchase Agreement
Soleno Therapeutics posts Q3 profit on strong VYKAT XR sales
Brief: Soleno Therapeutics Q3 EPS USD 0.47
U.S. STOCKS ON THE MOVE-Marvell, US energy companies, copper miners
Soleno Therapeutics rises after rival's rare disease drug fails late-stage study
Acadia falls as rare disease therapy fails late-stage trial
Acadia falls as rare disease therapy fails late-stage trial
Brief: Soleno Therapeutics Says Death Of Patient Not Related To VYKAT XR Treatment
U.S. STOCKS ON THE MOVE-Potbelly, Joby, Talen Energy
Soleno reports death of patient who took genetic disorder treatment, shares fall (updated)
Soleno Therapeutics slips after report of patient death
Soleno reports death of patient who took genetic disorder treatment
Soleno down after Scorpion Capital remains short
Brief: Scorpion Capital Says We Remain Short Soleno Therapeutics
Brief: Scorpion Capital Says Remain Short Soleno Therapeutics
U.S. STOCKS ON THE MOVE-Xcel Energy, Opendoor Technologies, Advance Auto Parts
U.S. STOCKS ON THE MOVE-Target, Precigen, Natgas companies
Scorpion Capital discloses short position in drugmaker Soleno (updated)
Soleno tumbles after Scorpion Capital takes a short position